A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
Abstract Background Testing for antibodies against podocyte phospholipase A2 receptor-1 (PLA2R) allows clinicians to accurately identify primary membranous nephropathy (MN). Secondary MN is associated with a spectrum of pathology including solid organ malignancy. PLA2R positivity in these patients o...
Main Authors: | David Mathew, Sanjana Gupta, Neil Ashman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-021-02511-x |
Similar Items
-
Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
by: Maxime Teisseyre, et al.
Published: (2020-05-01) -
Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor
by: Elías Jatem Escalante, et al.
Published: (2015-09-01) -
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
by: Yaling Guo, et al.
Published: (2020-01-01) -
Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide
by: Raja Ramachandran, et al.
Published: (2017-07-01) -
Current Concepts on Anti-Phospholipase A2 Receptor Antibody in Idiopathic Membranous Nephropathy
by: Hamid Nasri
Published: (2014-04-01)